Tracy B. McKibben - 14 Feb 2025 Form 4 Insider Report for ECOLAB INC. (ECL)

Role: Director
Signature: /s/ Youhao Dong, as Attorney-in-Fact for Tracy B. McKibben
Issuer symbol: ECL
Transactions as of: 14 Feb 2025
Transactions value $: -$157,898
Form type: 4
Filing time: 18 Feb 2025, 17:03:47 UTC
Previous filing: 03 Jan 2025
Next filing: 17 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ECL	Common Stock	Options Exercise	$293,137	+2,600	+29.42%	$112.74	11,438	14 Feb 2025	Direct
transaction	ECL	Common Stock	Sale	-$451,035	-1,704	-14.9%	$264.69	9,734	14 Feb 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ECL	Non-Employee Stock Option (Right to Buy)	Options Exercise	$0	-2,600	-100%	$0	0	14 Feb 2025	Common Stock	2,600	$112.74	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades at prices ranging from $264.64 to $264.80, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2	The option became exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the last day of the fourth three-month period following its date of grant. The date listed in the Date Exercisable column represents the first vesting date.

Content

This transaction was executed in multiple trades at prices ranging from $264.64 to $264.80, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The option became exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the last day of the fourth three-month period following its date of grant. The date listed in the Date Exercisable column represents the first vesting date.